ICMI 2015

Innate Lymphoid Cells

Friday, July 17, 2015: 3:15 PM-4:30 PM
Salon Dublin, Second Floor (Maritim Hotel)
Chair:
Hiroshi Kiyono, DDS, PhD
3:15 PM
Chair
3:30 PM
Crucial Role of Lymphotoxin Produced by ILC3 in the Development of Intestinal Adaptive Immune Responses and Autoimmunity
Andrey Kruglov, Lomonosov Moscow State University; Caroline Winsauer, DRFZ, a Leibniz Institute; Sergei Nedospasov, Engelhardt Institute of Molecular Biology
3:45 PM
ICOS Signaling Regulates Expansion of Group 2 Innate Lymphoid Cells Under Homeostatic and Inflammatory Conditions
Daniela Paclik, Deutsches Rheuma-Forschungszentrum; Christina Stehle, Deutsches Rheuma-Forschungszentrum; Annette Lahmann, Deutsches Rheuma-Forschungszentrum; Andreas Hutloff, Robert Koch Institute; Chiara Romagnani, Deutsches Rheuma-Forschungszentrum
4:00 PM
Type 3 Innate Lymphoid Cells Maintain Intestinal Epithelial Stem Cells After Tissue Damage
Patricia Aparicio-Domingo, Department of Hematology, Erasmus University Medical Center; Monica Romera Hernandez, Department of Hematology, Erasmus University Medical Center; Natalie Papazian, Department of Hematology, Erasmus University Medical Center; Julien J. Karrich, Department of Hematology, Erasmus University Medical Center; Ferry Cornelissen, Department of Hematology, Erasmus University Medical Center; Dicky Lindenbergh-Kortleve, Laboratory of Pediatrics, division Gastroenterology and Nutrition, Erasmus Medical Center; James A. Butler, Department of Electronics, University of York; Louis Boon, Bioceros; Mark C. Coles, Centre for Immunology and Infection, Department of Biology and Hull York Medical School; Janneke N. Samsom, Laboratory of Pediatrics, division Gastroenterology and Nutrition, Erasmus Medical Center; Tom Cupedo, Department of Hematology, Erasmus University Medical Center
4:15 PM
Coordinate Regulation of Inflammatory Responses by ILC3 and gp38+ Colonic Stromal Cells During Chronic Intestinal Inflammation.
Benjamin Owens, Ph.D., University of Oxford; Anna-Lena Schaupp, M.Sc., Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford; Nathaniel West, Ph.D., Kennedy Institute for Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; Ahmed Hegazy, M.D., Ph.D, Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford; Claire Pearson, Ph.D., Kennedy Institute for Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; Julie Schulthess, Ph.D., Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford; Mattias Svensson, Ph.D., Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital; Alison Simmons, M.D., Ph.D, Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford; Holm Uhlig, M.D., Ph.D, Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford; Fiona Powrie, Ph.D., Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford
See more of: Oral Abstract Sessions